• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Anemia Treatment Drugs Market Size, Status and Forecast 2020-2026

report cover
  • 22 June 2020
  • Pharmaceuticals
  • 93 Pages
  • Report Code: 24LS-8601
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Anemia Treatment Drugs -MARKET ADVISORY SERVICES

This report focuses on the global Anemia Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anemia Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Pfizer, Inc.
Amgen, Inc.
Hoffmann-La Roche Ltd.
Merck Sharp & Dohme Corp.
Novartis AG
Janssen Pharmaceutical
Bayer AG
AMAG Pharmaceuticals
GlaxoSmithKline plc
Akebia Therapeutics
Vifor Pharma Management, Ltd.
FibroGen, Inc.

Market segment by Type, the product can be split into
Supplements
Antibiotics
Immunosuppressant
Bone Marrow Stimulants
Corticosteroids
Gene Therapy
Iron Chelating Agents
Market segment by Application, split into
Iron deficiency anemia
Thalassemia
Aplastic anemia
Hemolytic anemia
Sickle cell anemia
Pernicious anemia

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Anemia Treatment Drugs status, future forecast, growth opportunity, key market and key players.
To present the Anemia Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anemia Treatment Drugs are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anemia Treatment Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Anemia Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Supplements
1.4.3 Antibiotics
1.4.4 Immunosuppressant
1.4.5 Bone Marrow Stimulants
1.4.6 Corticosteroids
1.4.7 Gene Therapy
1.4.8 Iron Chelating Agents
1.5 Market by Application
1.5.1 Global Anemia Treatment Drugs Market Share by Application: 2020 VS 2026
1.5.2 Iron deficiency anemia
1.5.3 Thalassemia
1.5.4 Aplastic anemia
1.5.5 Hemolytic anemia
1.5.6 Sickle cell anemia
1.5.7 Pernicious anemia
1.6 Coronavirus Disease 2019 (Covid-19): Anemia Treatment Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Anemia Treatment Drugs Industry
1.6.1.1 Anemia Treatment Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Anemia Treatment Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Anemia Treatment Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Anemia Treatment Drugs Market Perspective (2015-2026)
2.2 Anemia Treatment Drugs Growth Trends by Regions
2.2.1 Anemia Treatment Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anemia Treatment Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Anemia Treatment Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Anemia Treatment Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Anemia Treatment Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Anemia Treatment Drugs Players by Market Size
3.1.1 Global Top Anemia Treatment Drugs Players by Revenue (2015-2020)
3.1.2 Global Anemia Treatment Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Anemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anemia Treatment Drugs Market Concentration Ratio
3.2.1 Global Anemia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anemia Treatment Drugs Revenue in 2019
3.3 Anemia Treatment Drugs Key Players Head office and Area Served
3.4 Key Players Anemia Treatment Drugs Product Solution and Service
3.5 Date of Enter into Anemia Treatment Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Anemia Treatment Drugs Historic Market Size by Type (2015-2020)
4.2 Global Anemia Treatment Drugs Forecasted Market Size by Type (2021-2026)

5 Anemia Treatment Drugs Breakdown Data by Application (2015-2026)
5.1 Global Anemia Treatment Drugs Market Size by Application (2015-2020)
5.2 Global Anemia Treatment Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Anemia Treatment Drugs Market Size (2015-2020)
6.2 Anemia Treatment Drugs Key Players in North America (2019-2020)
6.3 North America Anemia Treatment Drugs Market Size by Type (2015-2020)
6.4 North America Anemia Treatment Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Anemia Treatment Drugs Market Size (2015-2020)
7.2 Anemia Treatment Drugs Key Players in Europe (2019-2020)
7.3 Europe Anemia Treatment Drugs Market Size by Type (2015-2020)
7.4 Europe Anemia Treatment Drugs Market Size by Application (2015-2020)

8 China
8.1 China Anemia Treatment Drugs Market Size (2015-2020)
8.2 Anemia Treatment Drugs Key Players in China (2019-2020)
8.3 China Anemia Treatment Drugs Market Size by Type (2015-2020)
8.4 China Anemia Treatment Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Anemia Treatment Drugs Market Size (2015-2020)
9.2 Anemia Treatment Drugs Key Players in Japan (2019-2020)
9.3 Japan Anemia Treatment Drugs Market Size by Type (2015-2020)
9.4 Japan Anemia Treatment Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Anemia Treatment Drugs Market Size (2015-2020)
10.2 Anemia Treatment Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anemia Treatment Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Anemia Treatment Drugs Market Size by Application (2015-2020)

11 India
11.1 India Anemia Treatment Drugs Market Size (2015-2020)
11.2 Anemia Treatment Drugs Key Players in India (2019-2020)
11.3 India Anemia Treatment Drugs Market Size by Type (2015-2020)
11.4 India Anemia Treatment Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Anemia Treatment Drugs Market Size (2015-2020)
12.2 Anemia Treatment Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Anemia Treatment Drugs Market Size by Type (2015-2020)
12.4 Central & South America Anemia Treatment Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer, Inc.
13.1.1 Pfizer, Inc. Company Details
13.1.2 Pfizer, Inc. Business Overview and Its Total Revenue
13.1.3 Pfizer, Inc. Anemia Treatment Drugs Introduction
13.1.4 Pfizer, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020))
13.1.5 Pfizer, Inc. Recent Development
13.2 Amgen, Inc.
13.2.1 Amgen, Inc. Company Details
13.2.2 Amgen, Inc. Business Overview and Its Total Revenue
13.2.3 Amgen, Inc. Anemia Treatment Drugs Introduction
13.2.4 Amgen, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020)
13.2.5 Amgen, Inc. Recent Development
13.3 Hoffmann-La Roche Ltd.
13.3.1 Hoffmann-La Roche Ltd. Company Details
13.3.2 Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
13.3.3 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Introduction
13.3.4 Hoffmann-La Roche Ltd. Revenue in Anemia Treatment Drugs Business (2015-2020)
13.3.5 Hoffmann-La Roche Ltd. Recent Development
13.4 Merck Sharp & Dohme Corp.
13.4.1 Merck Sharp & Dohme Corp. Company Details
13.4.2 Merck Sharp & Dohme Corp. Business Overview and Its Total Revenue
13.4.3 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Introduction
13.4.4 Merck Sharp & Dohme Corp. Revenue in Anemia Treatment Drugs Business (2015-2020)
13.4.5 Merck Sharp & Dohme Corp. Recent Development
13.5 Novartis AG
13.5.1 Novartis AG Company Details
13.5.2 Novartis AG Business Overview and Its Total Revenue
13.5.3 Novartis AG Anemia Treatment Drugs Introduction
13.5.4 Novartis AG Revenue in Anemia Treatment Drugs Business (2015-2020)
13.5.5 Novartis AG Recent Development
13.6 Janssen Pharmaceutical
13.6.1 Janssen Pharmaceutical Company Details
13.6.2 Janssen Pharmaceutical Business Overview and Its Total Revenue
13.6.3 Janssen Pharmaceutical Anemia Treatment Drugs Introduction
13.6.4 Janssen Pharmaceutical Revenue in Anemia Treatment Drugs Business (2015-2020)
13.6.5 Janssen Pharmaceutical Recent Development
13.7 Bayer AG
13.7.1 Bayer AG Company Details
13.7.2 Bayer AG Business Overview and Its Total Revenue
13.7.3 Bayer AG Anemia Treatment Drugs Introduction
13.7.4 Bayer AG Revenue in Anemia Treatment Drugs Business (2015-2020)
13.7.5 Bayer AG Recent Development
13.8 AMAG Pharmaceuticals
13.8.1 AMAG Pharmaceuticals Company Details
13.8.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 AMAG Pharmaceuticals Anemia Treatment Drugs Introduction
13.8.4 AMAG Pharmaceuticals Revenue in Anemia Treatment Drugs Business (2015-2020)
13.8.5 AMAG Pharmaceuticals Recent Development
13.9 GlaxoSmithKline plc
13.9.1 GlaxoSmithKline plc Company Details
13.9.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
13.9.3 GlaxoSmithKline plc Anemia Treatment Drugs Introduction
13.9.4 GlaxoSmithKline plc Revenue in Anemia Treatment Drugs Business (2015-2020)
13.9.5 GlaxoSmithKline plc Recent Development
13.10 Akebia Therapeutics
13.10.1 Akebia Therapeutics Company Details
13.10.2 Akebia Therapeutics Business Overview and Its Total Revenue
13.10.3 Akebia Therapeutics Anemia Treatment Drugs Introduction
13.10.4 Akebia Therapeutics Revenue in Anemia Treatment Drugs Business (2015-2020)
13.10.5 Akebia Therapeutics Recent Development
13.11 Vifor Pharma Management, Ltd.
10.11.1 Vifor Pharma Management, Ltd. Company Details
10.11.2 Vifor Pharma Management, Ltd. Business Overview and Its Total Revenue
10.11.3 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Introduction
10.11.4 Vifor Pharma Management, Ltd. Revenue in Anemia Treatment Drugs Business (2015-2020)
10.11.5 Vifor Pharma Management, Ltd. Recent Development
13.12 FibroGen, Inc.
10.12.1 FibroGen, Inc. Company Details
10.12.2 FibroGen, Inc. Business Overview and Its Total Revenue
10.12.3 FibroGen, Inc. Anemia Treatment Drugs Introduction
10.12.4 FibroGen, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020)
10.12.5 FibroGen, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Anemia Treatment Drugs Key Market Segments

Table 2. Key Players Covered: Ranking by Anemia Treatment Drugs Revenue

Table 3. Ranking of Global Top Anemia Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Anemia Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Supplements

Table 6. Key Players of Antibiotics

Table 7. Key Players of Immunosuppressant

Table 8. Key Players of Bone Marrow Stimulants

Table 9. Key Players of Corticosteroids

Table 10. Key Players of Gene Therapy

Table 11. Key Players of Iron Chelating Agents

Table 12. COVID-19 Impact Global Market: (Four Anemia Treatment Drugs Market Size Forecast Scenarios)

Table 13. Opportunities and Trends for Anemia Treatment Drugs Players in the COVID-19 Landscape

Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 15. Key Regions/Countries Measures against Covid-19 Impact

Table 16. Proposal for Anemia Treatment Drugs Players to Combat Covid-19 Impact

Table 17. Global Anemia Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 18. Global Anemia Treatment Drugs Market Size by Regions (US$ Million): 2020 VS 2026

Table 19. Global Anemia Treatment Drugs Market Size by Regions (2015-2020) (US$ Million)

Table 20. Global Anemia Treatment Drugs Market Share by Regions (2015-2020)

Table 21. Global Anemia Treatment Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 22. Global Anemia Treatment Drugs Market Share by Regions (2021-2026)

Table 23. Market Top Trends

Table 24. Key Drivers: Impact Analysis

Table 25. Key Challenges

Table 26. Anemia Treatment Drugs Market Growth Strategy

Table 27. Main Points Interviewed from Key Anemia Treatment Drugs Players

Table 28. Global Anemia Treatment Drugs Revenue by Players (2015-2020) (Million US$)

Table 29. Global Anemia Treatment Drugs Market Share by Players (2015-2020)

Table 30. Global Top Anemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Treatment Drugs as of 2019)

Table 31. Global Anemia Treatment Drugs by Players Market Concentration Ratio (CR5 and HHI)

Table 32. Key Players Headquarters and Area Served

Table 33. Key Players Anemia Treatment Drugs Product Solution and Service

Table 34. Date of Enter into Anemia Treatment Drugs Market

Table 35. Mergers & Acquisitions, Expansion Plans

Table 36. Global Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 37. Global Anemia Treatment Drugs Market Size Share by Type (2015-2020)

Table 38. Global Anemia Treatment Drugs Revenue Market Share by Type (2021-2026)

Table 39. Global Anemia Treatment Drugs Market Size Share by Application (2015-2020)

Table 40. Global Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 41. Global Anemia Treatment Drugs Market Size Share by Application (2021-2026)

Table 42. North America Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 43. North America Key Players Anemia Treatment Drugs Market Share (2019-2020)

Table 44. North America Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 45. North America Anemia Treatment Drugs Market Share by Type (2015-2020)

Table 46. North America Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 47. North America Anemia Treatment Drugs Market Share by Application (2015-2020)

Table 48. Europe Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 49. Europe Key Players Anemia Treatment Drugs Market Share (2019-2020)

Table 50. Europe Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 51. Europe Anemia Treatment Drugs Market Share by Type (2015-2020)

Table 52. Europe Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 53. Europe Anemia Treatment Drugs Market Share by Application (2015-2020)

Table 54. China Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 55. China Key Players Anemia Treatment Drugs Market Share (2019-2020)

Table 56. China Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 57. China Anemia Treatment Drugs Market Share by Type (2015-2020)

Table 58. China Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 59. China Anemia Treatment Drugs Market Share by Application (2015-2020)

Table 60. Japan Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 61. Japan Key Players Anemia Treatment Drugs Market Share (2019-2020)

Table 62. Japan Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 63. Japan Anemia Treatment Drugs Market Share by Type (2015-2020)

Table 64. Japan Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 65. Japan Anemia Treatment Drugs Market Share by Application (2015-2020)

Table 66. Southeast Asia Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 67. Southeast Asia Key Players Anemia Treatment Drugs Market Share (2019-2020)

Table 68. Southeast Asia Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 69. Southeast Asia Anemia Treatment Drugs Market Share by Type (2015-2020)

Table 70. Southeast Asia Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 71. Southeast Asia Anemia Treatment Drugs Market Share by Application (2015-2020)

Table 72. India Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 73. India Key Players Anemia Treatment Drugs Market Share (2019-2020)

Table 74. India Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 75. India Anemia Treatment Drugs Market Share by Type (2015-2020)

Table 76. India Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 77. India Anemia Treatment Drugs Market Share by Application (2015-2020)

Table 78. Central & South America Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)

Table 79. Central & South America Key Players Anemia Treatment Drugs Market Share (2019-2020)

Table 80. Central & South America Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 81. Central & South America Anemia Treatment Drugs Market Share by Type (2015-2020)

Table 82. Central & South America Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 83. Central & South America Anemia Treatment Drugs Market Share by Application (2015-2020)

Table 84. Pfizer, Inc. Company Details

Table 85. Pfizer, Inc. Business Overview

Table 86. Pfizer, Inc. Product

Table 87. Pfizer, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 88. Pfizer, Inc. Recent Development

Table 89. Amgen, Inc. Company Details

Table 90. Amgen, Inc. Business Overview

Table 91. Amgen, Inc. Product

Table 92. Amgen, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 93. Amgen, Inc. Recent Development

Table 94. Hoffmann-La Roche Ltd. Company Details

Table 95. Hoffmann-La Roche Ltd. Business Overview

Table 96. Hoffmann-La Roche Ltd. Product

Table 97. Hoffmann-La Roche Ltd. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 98. Hoffmann-La Roche Ltd. Recent Development

Table 99. Merck Sharp & Dohme Corp. Company Details

Table 100. Merck Sharp & Dohme Corp. Business Overview

Table 101. Merck Sharp & Dohme Corp. Product

Table 102. Merck Sharp & Dohme Corp. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 103. Merck Sharp & Dohme Corp. Recent Development

Table 104. Novartis AG Company Details

Table 105. Novartis AG Business Overview

Table 106. Novartis AG Product

Table 107. Novartis AG Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 108. Novartis AG Recent Development

Table 109. Janssen Pharmaceutical Company Details

Table 110. Janssen Pharmaceutical Business Overview

Table 111. Janssen Pharmaceutical Product

Table 112. Janssen Pharmaceutical Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 113. Janssen Pharmaceutical Recent Development

Table 114. Bayer AG Company Details

Table 115. Bayer AG Business Overview

Table 116. Bayer AG Product

Table 117. Bayer AG Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 118. Bayer AG Recent Development

Table 119. AMAG Pharmaceuticals Business Overview

Table 120. AMAG Pharmaceuticals Product

Table 121. AMAG Pharmaceuticals Company Details

Table 122. AMAG Pharmaceuticals Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 123. AMAG Pharmaceuticals Recent Development

Table 124. GlaxoSmithKline plc Company Details

Table 125. GlaxoSmithKline plc Business Overview

Table 126. GlaxoSmithKline plc Product

Table 127. GlaxoSmithKline plc Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 128. GlaxoSmithKline plc Recent Development

Table 129. Akebia Therapeutics Company Details

Table 130. Akebia Therapeutics Business Overview

Table 131. Akebia Therapeutics Product

Table 132. Akebia Therapeutics Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 133. Akebia Therapeutics Recent Development

Table 134. Vifor Pharma Management, Ltd. Company Details

Table 135. Vifor Pharma Management, Ltd. Business Overview

Table 136. Vifor Pharma Management, Ltd. Product

Table 137. Vifor Pharma Management, Ltd. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 138. Vifor Pharma Management, Ltd. Recent Development

Table 139. FibroGen, Inc. Company Details

Table 140. FibroGen, Inc. Business Overview

Table 141. FibroGen, Inc. Product

Table 142. FibroGen, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)

Table 143. FibroGen, Inc. Recent Development

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Anemia Treatment Drugs Market Share by Type: 2020 VS 2026

Figure 2. Supplements Features

Figure 3. Antibiotics Features

Figure 4. Immunosuppressant Features

Figure 5. Bone Marrow Stimulants Features

Figure 6. Corticosteroids Features

Figure 7. Gene Therapy Features

Figure 8. Iron Chelating Agents Features

Figure 9. Global Anemia Treatment Drugs Market Share by Application: 2020 VS 2026

Figure 10. Iron deficiency anemia Case Studies

Figure 11. Thalassemia Case Studies

Figure 12. Aplastic anemia Case Studies

Figure 13. Hemolytic anemia Case Studies

Figure 14. Sickle cell anemia Case Studies

Figure 15. Pernicious anemia Case Studies

Figure 16. Anemia Treatment Drugs Report Years Considered

Figure 17. Global Anemia Treatment Drugs Market Size YoY Growth 2015-2026 (US$ Million)

Figure 18. Global Anemia Treatment Drugs Market Share by Regions: 2020 VS 2026

Figure 19. Global Anemia Treatment Drugs Market Share by Regions (2021-2026)

Figure 20. Porter's Five Forces Analysis

Figure 21. Global Anemia Treatment Drugs Market Share by Players in 2019

Figure 22. Global Top Anemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Treatment Drugs as of 2019

Figure 23. The Top 10 and 5 Players Market Share by Anemia Treatment Drugs Revenue in 2019

Figure 24. North America Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. Europe Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 26. China Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 27. Japan Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 28. Southeast Asia Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 29. India Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 30. Central & South America Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 31. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 32. Pfizer, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 33. Amgen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 34. Amgen, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 35. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 36. Hoffmann-La Roche Ltd. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 37. Merck Sharp & Dohme Corp. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 38. Merck Sharp & Dohme Corp. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 39. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 40. Novartis AG Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 41. Janssen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 42. Janssen Pharmaceutical Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 43. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 44. Bayer AG Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 45. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 46. AMAG Pharmaceuticals Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 47. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018

Figure 48. GlaxoSmithKline plc Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 49. Akebia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. Akebia Therapeutics Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 51. Vifor Pharma Management, Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Vifor Pharma Management, Ltd. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 53. FibroGen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. FibroGen, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

Pfizer, Inc.

Amgen, Inc.

Hoffmann-La Roche Ltd.

Merck Sharp & Dohme Corp.

Novartis AG

Janssen Pharmaceutical

Bayer AG

AMAG Pharmaceuticals

GlaxoSmithKline plc

Akebia Therapeutics

Vifor Pharma Management, Ltd.

FibroGen, Inc.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3120

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase